Table 5. Description of responders.
| Age | Previous chemotherapy | Response to previous chemotherapy | Site of disease | Response to vinflunine | Cycles total (N) | Time to first response (months) |
|---|---|---|---|---|---|---|
| 62 | GC | NC | Lymph nodes | PR | 7 | 4.2 |
| 71 | GC | PD | Lymph nodes+lung | PR | 6 | 1.3 |
| 76 | CMV | PR | Lymph nodes | PR | 4 | 1.7 |
| 71 | GC | PR | Lymph nodes+lung | PR | 8 | 1.3 |
| 50 | GC | PR | Liver + lung | PR | 8 | 1.3 |
| 79 | GC | PR | Liver + lung | PR | 6 | 2.1 |
| 64 | M-VAC | PR | Lymph nodes | PR | 4 | 1.5 |
| 63 | GC | NA | Lymph nodes | PR | 8 | 1.3 |
| 45 | CMV + GC | CR | Lung | PR | 5 | 1.1 |
CMV=cisplatin, methotrexate, vinblastine; GC=gemcitabine, cisplatin; M-VAC=methotrexate, vinblastine, adriamycin, cisplatin.